3d bioprinting funding

Game-Changing $115M for Aspect Biosystems’ Bioprinted Tech

Pioneering solutions for metabolic and endocrine diseases, Vancouver-based Aspect Biosystems raised $115 million in Series B funding to advance its bioprinted tissue technology. Led by investment firm Dimension, the round…